These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis. Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628 [TBL] [Abstract][Full Text] [Related]
3. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. Banks C; Bateman A; Payne R; Johnson P; Sheron N J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223 [TBL] [Abstract][Full Text] [Related]
4. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine. Klebl FH; Olsen JE; Jain S; Doe WF J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698 [TBL] [Abstract][Full Text] [Related]
5. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease. Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292 [TBL] [Abstract][Full Text] [Related]
6. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. Kruidenier L; Kuiper I; Lamers CB; Verspaget HW J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T; May B; Pfisterer O; Müller KM; Brasch F Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933 [TBL] [Abstract][Full Text] [Related]
8. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction. Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554 [TBL] [Abstract][Full Text] [Related]
9. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335 [TBL] [Abstract][Full Text] [Related]
12. The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids. Yang SK; Choi MS; Kim OH; Myung SJ; Jung HY; Hong WS; Kim JH; Min YI Am J Gastroenterol; 2002 Jan; 97(1):126-32. PubMed ID: 11808935 [TBL] [Abstract][Full Text] [Related]
15. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis. Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510 [TBL] [Abstract][Full Text] [Related]
16. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease. Stadnicki A; Mazurek U; Plewka D; Wilczok T Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351 [TBL] [Abstract][Full Text] [Related]
17. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. Masuda H; Iwai S; Tanaka T; Hayakawa S J Clin Lab Immunol; 1995; 46(3):111-23. PubMed ID: 8926619 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease. Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392 [TBL] [Abstract][Full Text] [Related]
20. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Krishna M; Woda B; Savas L; Baker S; Banner B Mod Pathol; 1995 Aug; 8(6):654-7. PubMed ID: 8532700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]